Non-small cell lung cancer in never smokers as a representative 'non-smoking-associated lung cancer': Epidemiology and clinical features

International Journal of Clinical Oncology

Volumn 16, Issue 4, 2011, Pages 287-293

  Yano, Tokujiro ^a   Haro, Akira ^a   Shikada, Yasunori ^a   Maruyama, Riichiroh ^a   Maehara, Yoshihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

EGFR mutation; Estrogen; Lung cancer; Never smokers; Postoperative survival; Secondhand smoking

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; CISPLATIN; ECHINODERM MICROTUBULE ASSOCIATED PROTEIN 4; ERLOTINIB; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GEFITINIB; GEMCITABINE; MICROTUBULE ASSOCIATED PROTEIN 4; PEMETREXED; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADENOCARCINOMA; CANCER INCIDENCE; CANCER RISK; CLINICAL FEATURE; DIET; EGFR GENE; EML4 ALK GENE; FAMILY HISTORY; GENDER; GENE EXPRESSION; GENE MUTATION; HUMAN; LUNG DISEASE; LUNG NON SMALL CELL CANCER; NON SMOKING; NON SMOKING ASSOCIATED LUNG CANCER; OCCUPATIONAL EXPOSURE; ONCOGENE; OUTCOME ASSESSMENT; PASSIVE SMOKING; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; SMOKING;

ADENOCARCINOMA; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; OCCUPATIONAL EXPOSURE; ONCOGENE PROTEINS, FUSION; RECEPTOR, EPIDERMAL GROWTH FACTOR; RISK FACTORS; SMOKING; TOBACCO SMOKE POLLUTION;

EID: 80052732697     PISSN: 13419625     EISSN: 14377772     Source Type: Journal    
DOI: 10.1007/s10147-010-0160-8     Document Type: Review

References (75)

1. HA Wakelee ET Chang SL Gomez, et al. 2007 Lung cancer incidence in never smokers J Clin Oncol 25 472 478 17290054 10.1200/JCO.2006.07.2983 (Pubitemid 350002951)
2. P Boffetta B Jarvholm P Brennan, et al. 2001 Incidence of lung cancer in a large cohort of non-smoking men from Sweden Int J Cancer 94 591 593 11745449 10.1002/ijc.1507 1:CAS:528:DC%2BD3MXns1Gnu7w%3D (Pubitemid 32979554)
3. CK Toh F Gao WT Lim, et al. 2006 Never-smokers with lung cancer. Epidemiologic evidence of a distinct disease entity J Clin Oncol 24 2245 2251 16710022 10.1200/JCO.2005.04.8033 (Pubitemid 46630653)
4. LC Koo JH Ho 1990 Worldwide epidemiological patterns of lung cancer in nonsmokers Int J Epidemiol 19 S14 S23 2258272
5. GA Colditz JE Mason SE Hankinson 1997 The Nurses' Health Study: 20-year contribution to the understanding of health among women J Womens Health 6 49 62 9065374 10.1089/jwh.1997.6.49 1:STN:280:DyaK2s3hslGnuw%3D%3D
6. EB Rimm MJ Stampfer GA Colditz, et al. 1990 Effectiveness of various mailing strategies among nonrespondents in a prospective cohort study Am J Epidemiol 131 1068 1071 2343859 1:STN:280:DyaK3c3mtFKqsg%3D%3D (Pubitemid 20178628)
7. L Bemstein M Allen H Anton-Culver, et al. 2002 High breast cancer incidence rates among California teachers: results from the California Teachers Study (United States) Cancer Causes Control 13 625 635 10.1023/A:1019552126105 (Pubitemid 35001770)
8. LN Kolonel BE Henderson JH Hankin, et al. 2000 A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics Am J Epidemiol 151 346 357 10695593 1:STN:280:DC%2BD3c7lvVWnsg%3D%3D (Pubitemid 30463612)
9. CA Haiman DO Stram KR Wilkens, et al. 2006 Ethnic and racial differences in the smoking-related risk of lung cancer N Engl J Med 354 333 342 16436765 10.1056/NEJMoa033250 1:CAS:528:DC%2BD28Xns1Olsg%3D%3D (Pubitemid 43145058)
10. Lamberg K, Wagenius G, Garmo H et al (2004) Lung cancer in the Uppsala/Orebro region: register for lung cancer: account of materials for 1995-2003. Regional Oncological Center, Uppsala, Sweden
11. LC Yong CC Brown A Schatzkin, et al. 1997 Intake of vitamins E, C, and A and risk of lung cancer: The NHANES I epidemiologic followup study Am J Epidemiol 146 231 243 9247007 1:STN:280:DyaK2szovF2mtw%3D%3D (Pubitemid 27329724)
12. ND Freedman MF Leitzmann AR Hollenbeck, et al. 2008 Cigarette smoking and subsequent risk of lung cancer in men and women: analysis of a prospective cohort study Lancet Oncol 19 1391 1399
13. MJ Thun LM Hannan LL Adams-Campbell, et al. 2008 Lung cancer occurrence in never-smokers: an analysis of 13 cohorts and 22 cancer registry studies PLOS Med 5 1357 1371 10.1371/journal.pmed.0050185
14. RC Brownson MCR Alavanja N Caporaso, et al. 1998 Epidemiology and prevention of lung cancer in nonsmokers Epidemiol Rev 20 218 236 9919440 1:STN:280:DyaK1M7hvVSrtg%3D%3D (Pubitemid 29045108)
15. L Zhong MS Goldberg M Parent, et al. 2000 Exposure to environmental tobacco smoke and the risk of lung cancer: a meta-analysis Lung Cancer 27 3 18 10672779 10.1016/S0169-5002(99)00093-8 1:STN:280:DC%2BD3c7jsFegtg%3D%3D
16. P Brennan PA Buffler P Reynolds, et al. 2004 Secondhand smoke exposure in adulthood and risk of lung cancer among never smokers: a pooled analysis of two large studies Int J Cancer 109 125 131 14735478 10.1002/ijc.11682 1:CAS:528:DC%2BD2cXhs1Smur8%3D (Pubitemid 38160672)
17. N Kurahashi M Inoue Y Liu, et al. 2008 Passive smoking and lung cancer in Japanese non-smoking women: a prospective study Int J Cancer 122 653 657 17935128 10.1002/ijc.23116 1:CAS:528:DC%2BD1cXhsVelsA%3D%3D (Pubitemid 350308961)
18. A Zeka A Mannetje D Zaridze, et al. 2006 Lung cancer and occupation in nonsmokers: a multicenter case-control study in Europe Epidemiology 17 615 623 17068414 10.1097/01.ede.0000239582.92495.b5 (Pubitemid 44655597)
19. DR Brenner RJ Hung MS Tsao, et al. 2010 Lung cancer risk in never-smokers: a population-based case-control study of epidemiologic risk factors BMC Cancer 10 285 20546590 10.1186/1471-2407-10-285
20. AH Wu ETH Fontham P Reynolds, et al. 1995 Previous lung disease and lung cancer among lifetime nonsmoking women in the United States Am J Epidemiol 141 1023 1032 7771438 1:STN:280:DyaK2M3ovFemsw%3D%3D
21. HY Liang XL Li XS Yu, et al. 2009 Facts and fiction of the relationship between preexisting tuberculosis and lung cancer risk: a systemic review Int J Cancer 125 2936 2944 19521963 10.1002/ijc.24636 1:CAS:528:DC%2BD1MXhtlSqsLvJ
22. JA Park HJ Park JS Lee, et al. 2008 Adenocarcinoma of lung in never smoked children Lung Cancer 61 266 269 18394748 10.1016/j.lungcan.2008.02.016
23. H Okazaki S Takayama T Sugimura 1991 Carcinogenicities of heterocyclic amines in cooked food Mutat Res 259 399 410 10.1016/0165-1218(91)90130-E
24. M Reinik T Tamme M Roasto, et al. 2007 Polycyclic aromatic hydrocarbons (PHAs) in meat products and estimated PAH intake by children and the general population in Estonia Food Addit Contam 24 429 437 17454117 10.1080/ 02652030601182862 1:CAS:528:DC%2BD2sXjvVygt74%3D (Pubitemid 46534169)
25. SS Mirvish 1977 N-nitroso compounds: their chemical and in vitro formation and possible importance as environmental carcinogens J Toxicol Environ Health 2 1267 1277 328917 10.1080/15287397709529529 1:CAS:528: DyaE2sXls1ahsb0%3D (Pubitemid 8151317)
26. JM McCord 1998 Iron, free radicals, and oxidative injury Semin Hematol 35 5 12 9460805 1:CAS:528:DyaK1cXntVCktQ%3D%3D (Pubitemid 28047038)
27. X Hung 2003 Iron overload and its association with cancer risk in humans: evidence for iron as a carcinogenic metal Mutat Res 533 153 171
28. AJ Cross MF Leitzmann MH Gail, et al. 2007 A prospective study of red and processed meat intake in relation to cancer risk PloS Med 4 1973 1984 10.1371/journal.pmed.0040325
29. N Tasevska R Sinha V Kipnis, et al. 2009 A prospective study of meat, cooking methods, meat mutagens, heme iron, and lung cancer risks Am J Clin Nutr 89 1884 1894 19369370 10.3945/ajcn.2008.27272 1:CAS:528:DC%2BD1MXms1ejtr8%3D
30. LP Stabile AL Davis CT Gubish, et al. 2002 Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptors alpha and beta and show biological responses to estrogen Cancer Res 62 2141 2150 11929836 1:CAS:528:DC%2BD38XivVylu7k%3D (Pubitemid 34408463)
31. MG Raso C Behrens MH Herynk, et al. 2009 Immunohistochemical expression of estrogen and progesterone receptors identifies a subset of NSCLCs and correlates with EGFR mutation Clin Cancer Res 15 5359 5368 19706809 10.1158/1078-0432.CCR-09-0033 1:CAS:528:DC%2BD1MXhtVOntrjN
32. N Nose K Sugio T Oyama, et al. 2009 Association between estrogen receptor β expression and epidermal growth factor receptor mutation in the postoperative prognosis of adenocarcinoma of the lung J Clin Oncol 27 411 417 19064969 10.1200/JCO.2008.18.3251 1:CAS:528:DC%2BD1MXitF2gsbo%3D
33. T Shimazu M Inoue S Sasazuki, et al. 2010 Isoflavone intake and risk of lung cancer: a prospective cohort study in Japan Am J Clin Nutr 91 722 728 20071645 10.3945/ajcn.2009.28161 1:CAS:528:DC%2BC3cXisFynurc%3D
34. A Seow WP Koh R Wang, et al. 2009 Reproductive variables, soy intake, and lung cancer risk among nonsmoking women in the Singapore Chinese Health Study Cancer Epidemiol Biomarkers Prev 18 821 827 19240237 10.1158/1055-9965.EPI-08- 0892 1:CAS:528:DC%2BD1MXivVOlsLk%3D
35. GG Kuiper JG Lemmen B Carlsson, et al. 1998 Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta Endocrinology 139 4252 4263 9751507 10.1210/en.139.10.4252 1:CAS:528:DyaK1cXmsVGmsrw%3D (Pubitemid 28513713)
36. T Kohno R Kakinuma M Iwasaki, et al. 2010 Association of CYP19A1 polymorphisms with risks for atypical adenomatous hyperplasia and bronchioloalveolar carcinoma in the lungs Carcinogenesis 31 1794 1799 20688833 10.1093/carcin/bgq159 1:CAS:528:DC%2BC3cXht1Ogtb%2FF
37. A Matakidou T Eisen H Bridle, et al. 2005 Case-control study of familial lung cancer risks in UK women Int J Cancer 116 445 450 15800943 10.1002/ijc.21012 1:CAS:528:DC%2BD2MXmtl2kurk%3D (Pubitemid 40993343)
38. CJ Etzel CI Amos MR Spitz 2003 Risk for smoking-related cancer among relatives of lung cancer patients Cancer Res 63 8531 8535 14679021 1:CAS:528:DC%2BD3sXpvVagu7w%3D (Pubitemid 37549512)
39. BJ Lorenzo K Hemminski 2005 Familial lung cancer and aggregation of smoking habits: a simulation of the effect of shared environmental factors on the familial risk of cancer Cancer Epidemiol Biomarkers Prev 14 1738 1740 10.1158/1055-9965.EPI-05-0201 (Pubitemid 40995088)
40. J Nitadori M Inoue M Iwasaki, et al. 2006 Association between lung cancer incidence and family history of lung cancer Chest 130 968 975 17035426 10.1378/chest.130.4.968 (Pubitemid 44583723)
41. T Okasaka K Matsuo T Suzuki, et al. 2009 hOGG1 Ser326Cys polymorphism and risk of lung cancer by histological type J Hum Genet 54 739 745 19881468 10.1038/jhg.2009.108 1:CAS:528:DC%2BD1MXhs1Sqsb7N
42. CM Shih CY Chen IH Lee, et al. 2010 A polymorphism in the hMLH1 gene (-93G- > A) associated with lung cancer susceptibility and prognosis Int J Mol Med 25 165 170 19956916 1:CAS:528:DC%2BC3cXhtFKqsb3J
43. KA Yoon JH Kim HJ Gil, et al. 2008 CYP1B1, CYP1A1, MPO, and GSTP1 polymorphisms and lung cancer risk in never-smoking Korean women Lung Cancer 60 40 46 17980933 10.1016/j.lungcan.2007.09.009 (Pubitemid 351434467)
44. T Yano N Miura T Takenaka, et al. 2008 Never-smoking non-small cell lung cancer as a separate entity-the clinico-pathologic features and survival Cancer 113 1012 1018 18618510 10.1002/cncr.23679
45. JA Zell SH Ou A Ziogas, et al. 2005 Epidemiology of bronchioloalveolar carcinoma: improvement in survival after release of the 1999 WHO classification of lung tumors J Clin Oncol 23 8396 8405 16293870 10.1200/JCO.2005.03.0312
46. T Fujisawa T Lizasa Y Saitoh, et al. 1999 Smoking before surgery predicts poor long-term survival in patients with stage I non-small-cell lung carcinomas J Clin Oncol 17 2086 2091 10561262 1:STN:280:DC%2BD3c%2FivF2qsw%3D%3D (Pubitemid 29318839)
47. T Sioris K Husgafvel-Pursiainen A Karjalainen, et al. 2000 Survival in operable non-small-cell lung cancer: role of p53 mutations, tobacco smoking and asbestos exposure Int J Cancer 86 590 594 10797276 10.1002/(SICI)1097- 0215(20000515)86:4<590::AID-IJC23>3.0.CO;2-E 1:CAS:528: DC%2BD3cXjtlyksb4%3D (Pubitemid 30249743)
48. CM Tammenagi C Neslund-Dudas M Simoff, et al. 2004 Smoking and lung cancer survival Chest 125 27 37 10.1378/chest.125.1.27 (Pubitemid 38114560)
49. PS Nia J Weyler C Colpaert, et al. 2005 Prognostic value of smoking status in operated non-small cell lung cancer Lung Cancer 47 351 359 10.1016/j.lungcan.2004.08.011 (Pubitemid 40248739)
50. I Yoshino D Kawano Oba Taro, et al. 2006 Smoking status as a prognostic factor in patients with stage I pulmonary adenocarcinoma Ann Thorac Surg 81 1189 1193 16564239 10.1016/j.athoracsur.2005.09.028
51. T Mitsudomi M Tateishi T Oka, et al. 1989 Longer survival after non-small cell lung cancer in Japanese women Ann Thorac Surg 48 639 642 2554828 10.1016/0003-4975(89)90779-0 1:STN:280:DyaK3c%2FlsFCmsw%3D%3D (Pubitemid 19270431)
52. JB Fu TY Kau RK Severson, et al. 2005 Lung cancer in women. Analysis of the national surveillance, epidemiology, and end results database Chest 127 768 777 15764756 10.1378/chest.127.3.768 (Pubitemid 40775504)
53. M Perrot M Licker A Spiliopoulous, et al. 2000 Sex differences in presentation, management and prognosis of patients with non-small cell lung carcinoma J Thorac Cardiovasc Surg 119 21 26 10612756 10.1016/S0022-5223(00) 70213-3 (Pubitemid 30046309)
54. MK Ferguson J Wang E Vokes, et al. 2000 Sex-associated differences in survival of patients undergoing resection for lung cancer Ann Thorac Surg 69 245 250 10654523 10.1016/S0003-4975(99)01078-4 1:STN:280:DC%2BD3c7hvVKrtg%3D%3D (Pubitemid 30078857)
55. Y Sekine H Suzuki T Nakajima, et al. 2010 Risk quantification for pulmonary complications after lung cancer surgery Surg Today 40 1027 1033 21046500 10.1007/s00595-009-4182-7
56. T Hanagiri K Sugio M Mizukami, et al. 2008 Significance of smoking as a postoperative prognostic factor with non-small cell lung cancer J Thorac Oncol 3 1127 1132 18827608 10.1097/JTO.0b013e318186fafb
57. J Subramanian V Velcheti F Gao, et al. 2007 Presentation and stage-specific outcomes of lifelong never-smokers with non-small cell lung cancer (NSLLC) J Thorac Oncol 2 827 830 17805060 10.1097/JTO.0b013e318145af79 (Pubitemid 47361024)
58. LT Nordquist GR Simon A Cantor, et al. 2004 Improved survival in never-smokers vs current smokers with primary adenocarcinoma of the lung Chest 126 347 351 15302716 10.1378/chest.126.2.347 (Pubitemid 39093415)
59. T Kawaguchi M Takada A kubo, et al. 2010 Gender, histology, and time of diagnosis are important factors for prognosis. Analysis of 1499 never-smokers with advanced non-small cell lung cancer in Japan J Thorac Oncol 5 1011 1017 20502360
60. GV Scagliotti P Parikh J von Pawel, et al. 2008 Phase III comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naïve patients with advanced-stage non-small-cell lung cancer J Clin Oncol 26 3543 3551 18506025 10.1200/JCO.2007.15.0375 1:CAS:528: DC%2BD1cXpvVWmtLg%3D
61. JG Paez PA Janne JC Lee, et al. 2004 EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy Science 304 1479 1500 10.1126/science.1099314 (Pubitemid 38720929)
62. W Pao V Miller M Zakowski, et al. 2004 EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib Proc Natl Acad Sci 101 13306 13311 15329413 10.1073/pnas.0405220101 1:CAS:528:DC%2BD2cXnvFems70%3D (Pubitemid 39209661)
63. TJ Lynch DW Bell R Sordella, et al. 2004 Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib N Engl J Med 350 2129 2139 15118073 10.1056/NEJMoa040938 1:CAS:528:DC%2BD2cXktF2js7c%3D (Pubitemid 38637993)
64. R Rosell T Moran C Queralt, et al. 2009 Screening for epidermal growth factor receptor mutations in lung cancer N Engl J Med 361 958 967 19692684 10.1056/NEJMoa0904554 1:CAS:528:DC%2BD1MXhtVOqsL7M
65. DM Jackman VA Miller LA Cioffredi, et al. 2009 Impact of epidermal growth factor receptor and KRAS mutations on clinical outcomes in previously untreated non-small cell lung cancer patients: Results of an online tumor registry of clinical trials Clin Cancer Res 15 5267 5273 19671843 10.1158/1078-0432.CCR-09- 0888 1:CAS:528:DC%2BD1MXpvFeitLs%3D
66. T Kosaka Y Yatabe H Endoh, et al. 2004 Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications Cancer Res 64 8919 8923 15604253 10.1158/0008-5472.CAN-04-2818 1:CAS:528: DC%2BD2cXhtVOmsL3P (Pubitemid 39665498)
67. M Satouchi S Negoro Y Funada, et al. 2007 Predictive factors associated with prolonged survival in patients with advanced non-small-cell lung cancer (NSCLC) treated with gefitinib Br J Cancer 96 1191 1196 17387341 10.1038/sj.bjc.6603710 1:CAS:528:DC%2BD2sXkt1GqtL0%3D (Pubitemid 46625078)
68. YJ Lee BC Cho SH Jee, et al. 2010 Impact of environmental tobacco smoke on the incidence of mutations in epidermal growth factor receptor gene in never-smoker patients with non-small-cell lung cancer J Clin Oncol 28 487 492 20008630 10.1200/JCO.2009.24.5480 1:CAS:528:DC%2BC3cXivFartbs%3D
69. H Bai L Mao hS Wang, et al. 2009 Epidermal growth factor receptor mutations in plasma DNA samples predict tumor response in Chinese patients with stages IIIB to IV non-small-cell lung cancer J Clin Oncol 27 2653 2659 19414683 10.1200/JCO.2008.17.3930 1:CAS:528:DC%2BD1MXnslWit7c%3D
70. DK Pham MG Kris GJ Riely, et al. 2006 Use of cigarette-smoking history to estimate the likelihood of mutations in epidermal growth factor receptor gene exons 19 and 21 in lung adenocarcinomas J Clin Oncol 24 1700 1704 16505411 10.1200/JCO.2005.04.3224 1:CAS:528:DC%2BD28XksVKgtLY%3D (Pubitemid 46622141)
71. M Soda YL Choi M Enomoto, et al. 2007 Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer Nature 448 561 566 17625570 10.1038/nature05945 1:CAS:528:DC%2BD2sXosVSrtrs%3D (Pubitemid 47206930)
72. JP Koivunen C Mermel K Zejnullahu, et al. 2008 EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer Clin Cancer Res 14 4275 4283 18594010 10.1158/1078-0432.CCR-08-0168 1:CAS:528:DC%2BD1cXnvFyks7s%3D
73. DW Wong EL Leung KK So, et al. 2009 The EML4-ALK fusion gene is involved in various histologic types of lung cancers from nonsmokers with wild-type EGFR and KRAS Cancer 115 1723 1733 19170230 10.1002/cncr.24181 1:CAS:528: DC%2BD1MXltVOnur4%3D
74. AT Shaw BY Yeap M Mino-Kenudson, et al. 2009 Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK J Clin Oncol 27 4247 4253 19667264 10.1200/JCO.2009.22.6993 1:CAS:528: DC%2BD1MXht1WisbvF
75. EL Kwak YJ Bang DR Camidge, et al. 2010 Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer N Engl J Med 363 1693 1703 20979469 10.1056/NEJMoa1006448 1:CAS:528:DC%2BC3cXhtlKitL%2FO